NCT04464694 Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema Status UNKNOWN Phase PHASE4
NCT04455399 Time Efficiency Comparison of Two IntraVitreal Injection Techniques Status COMPLETED Phase NA
NCT04432831 A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT04429503 Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease Status COMPLETED Phase PHASE2/PHASE3
NCT04411693 Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema Status COMPLETED Phase PHASE4
NCT04395859 Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents Status COMPLETED Phase N/A
NCT04387604 Effect of the Vitreous in Response to Intravitreal Injections of Ranibizumab for the Treatment of Diabetic Macular Edema Status COMPLETED Phase N/A
NCT04332133 Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular Edema Status COMPLETED Phase NA
NCT04254536 Changes in Optical Coherence Tomography Leakage Mapping in Diabetic Macular Edema After Conbercept Treatment Status UNKNOWN Phase N/A
NCT04187443 MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema Status RECRUITING Phase PHASE1
NCT04151407 The Study of Drug 601 in Patients With Diabetic Macular Edema (DME) Status UNKNOWN Phase PHASE1
NCT04142164 Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections Status UNKNOWN Phase NA
NCT04116398 Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema (LOADEX) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04108156 A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME Status RECRUITING Phase PHASE3
NCT04089605 Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema Status COMPLETED Phase PHASE4
NCT04087746 Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME) Status COMPLETED Phase PHASE4
NCT04085341 A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion Status COMPLETED Phase PHASE2
NCT04067856 Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery Status WITHDRAWN Phase NA